Anacor Pharmaceuticals is not yet claimed on DailyTalent
Is this your business? Claim your ownership through an easy verification process.
Anacor is a biopharmaceutical company focused on discovering, developing and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. Anacor has discovered and is developing five clinical compounds, including its three lead programs: AN2690, a topical antifungal for the treatment of onychomycosis; AN2728, a topical anti-inflammatory PDE-4 inhibitor for the treatment of psoriasis; and GSK 2251052, or GSK '052 (formerly referred to as AN3365), a systemic antibiotic for the treatment of infections caused by Gram-negative bacteria, which has been licensed to GlaxoSmithKline under the companies' research and development agreement. In addition, Anacor is developing AN2718 as a topical antifungal product candidate for the treatment of onychomycosis and skin fungal infections, and AN2898 as a topical anti-inflammatory product candidate for the treatment of psoriasis and atopic dermatitis.
Anacor Pharmaceuticals is not yet claimed on DailyTalent
Is this your business? Claim your ownership through an easy verification process.
Company Overview
Anacor Pharmaceuticals is a Public Company company located in Palo Alto, CA. This company specializes in Pharmaceuticals and has a workforce of 0-1 employees and is always looking for qualified talent. Learn more by visiting Anacor Pharmaceuticals's website , Linkedin or Social Feed.
Anacor Pharmaceuticals values experience and skills such as
Pharma Service Skills, Clinical Pharmacology,.
Software or tools they use are
Microsoft Excel, Microsoft Word, Microsoft Access, Microsoft PowerPoint, and others.
Showcase Video
Specialty Services
At Anacor Pharmaceuticals we specialize in Anacor develops novel small-molecule therapeutics derived from its boron chemistry platform.
